Rift Biotherapeutics, Inc. — Form D
Rift Biotherapeutics, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2017-04-03. The offering totals $3.6M, of which $2.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-04-03
- Form: D
- Accession: 0001702583-17-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.6M
- Amount sold: $2.1M
- Remaining: $1.5M
- Investors: 4
- Date of first sale: 2017-03-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-283942
Issuer
- Name: Rift Biotherapeutics, Inc.
- CIK: 0001702583
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 6335 NANCY RIDGE DRIVE, SAN DIEGO, CA, 92121
- Phone: (949) 632-3568
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Miguel de los Rios | Director | San Diego, CA |
| Briggs Morrison | Director | Cambridge, MA |
| Ian Walters | Director | Evanston, IN |
| Cornelia Bentley | Executive Officer | SAN DIEGO, CA |
| Jill Bentley | Executive Officer | SAN DIEGO, CA |
| Miguel de los Rios | Executive Officer | San Diego, CA |
More